Patient profile Name: Madam N Age: 37 Occupation: Clinic assistant Address: Shah Alam Parity index: G3P2 Period of Gestation: 38 weeks 2 days Last Menstrual Period: 11th October 2025 Expected Date of Delivery: 18th July 2026 Date of Admission: 5th July 2026 Date of examination: 6th July 2026 Chief Complaint Patient was leaking per vagina for 17 hours ago from 10pm on 5th July 2026. History of Presenting Illness Madam N was well until approximately 10.00 pm on 5 July 2026, when she suddenly experienced a l gush of fluid while she was at home, causing her clothes soaked. The fluid was clear, colourless, odourless and not blood-stained. Following the initial gush, the leakage became intermittent, and she had changed approximately five sanitary pads due to the persistent leakage. She also complained of lower back pain radiating to the lower abdomen, with a pain score of 2/10. There were no aggravating or relieving factors. She denied fever, chills, foul-smelling vaginal discharge, vaginal bleeding, dysuria, urinary frequency, urgency, vaginal itchiness or symptoms suggestive of urinary tract infection. Fetal movements remained good throughout, and there were no symptoms suggestive of pre-eclampsia such as headache, blurring of vision or epigastric pain. She reported experiencing a similar episode of leaking liquor during her first pregnancy. She initially sought treatment at Muadzam Shah Hospital, where cardiotocography (CTG) was reactive, bedside ultrasonography showed a normal amniotic fluid index, and vaginal examination revealed 2 cm cervical dilatation. She was subsequently referred to Hospital Tengku Ampuan Afzan for further management. On arrival, repeat assessment demonstrated a reactive CTG with reassuring fetal status. Repeat vaginal examination showed the cervix remained 2 cm dilated. She declined opioid analgesia, and intravenous antibiotic was administered. History of Presenting Pregnancy 1st trimester This was a planned pregnancy. The patient first noticed amenorrhea and performed a home urine pregnancy test one week after her missed menstrual period, which was positive. Pregnancy was subsequently confirmed by ultrasonography at a private clinic at 8 weeks' gestation. She booked for antenatal care at 14 weeks' gestation at Klinik Kesihatan Shah Alam. Booking investigations were unremarkable, with hemoglobin within the normal range, blood group O positive, normal urine examination, non-reactive serology test, and normal blood pressure. Her booking weight was 65 kg and height was 159 cm, giving a body mass index (BMI) of 25.7 kg/m², which is classified as overweight. During the first trimester, she experienced morning sickness characterized by nausea and vomiting and was commenced on folic acid and iron supplementation. Nuchal translucency screening was normal, and a modified glucose tolerance test (MGTT), performed because of her previous history of delivering a macrocosmic infant, was also normal. She attended regular antenatal follow-up visits every 4 weeks once and remained well throughout the trimester, with no vaginal bleeding, leaking of liquor, pruritus, or skin rashes. 2nd trimester During 2nd trimester, she first perceived quickening at 20 weeks. A detailed anomaly scan performed at 28 weeks was normal. Blood pressure, urine examination and blood investigations remained normal. Antenatal supplements were continued and she attended follow-up two weeks once. Tetanus toxoid vaccination was completed at. The 2nd trimester was otherwise uneventful. 3rd trimester During the third trimester, fetal growth remained appropriate. No formal growth scan was performed. Maternal weight gain was appropriate which is 12kg. Ten fetal kick count was completed by 3pm and bedside ultrasonography estimated the fetal weight to be approximately 3.2 kg. She received her one tetanus toxoid dose at 36 weeks of gestation. The 3rd trimester was otherwise uneventful. Menstrual history Madam N attained menarche at 13 years of age. Her menstrual cycles are regular, occurring every 28 to 30 days, with a flow duration of 5 to 6 days. There was no history of intermenstrual bleeding, postcoital bleeding, or abnormal vaginal discharge prior to this pregnancy. Oral contraceptives were not taken, and pap smear was done which is normal. Past pregnancy First pregnancy (2007) She delivered at 40 weeks’ gestation via spontaneous vaginal delivery a healthy male infant weighing 4.3 kg. The pregnancy was complicated by fetal macrosomia. The baby developed neonatal jaundice requiring phototherapy for approximately one month. He was breastfed for six months, completed all childhood immunisations and has normal growth and development. Second pregnancy (2013) She delivered at 38 weeks’ gestation via spontaneous vaginal delivery a healthy male infant weighing 3.6 kg. There were no antenatal, intrapartum or postpartum complications. The baby was breastfed for six months, completed immunisation and remains healthy. Past medical and surgical She has no known medical illnesses. She has no previous major surgery except for breast abscess surgery which incision and drainage. Family history Her mother has hypertension. Her father has ischemic heart disease. She has two healthy siblings. There is no family history of diabetes mellitus, congenital anomalies or inherited disorders. Personal history She reports normal appetite, sleep, bowel and bladder habits. She consumes a mixed diet. She does not smoke, consume alcohol or use illicit drugs. She has no known drug or food allergies. Socioecomic history She is married for 18 years, and she lives with her husband and two children in Shah Alam. Her husband is a lorry driver. The family has sufficient income and lives in a good home environment. Summary Madam N is a 37-year-old G3P2 at 38weeks and 2 days of gestation (LMP: 11th October 2025 ; EDD: 18th July 2026) who presented on 5th July 2026 for leaking per vagina for 17 hours ago from 10pm on 5th July 2026. She is currently on antibiotics. General examination Date of examination: 6th July 2026 • Patient is lying down comfortably in supine position on bed. She is moderately built and is • moderately nourished. • Her height is 156 cm, weight is 59 kg and BMI is 24.2 kg/m^2. Prescence of IV cannula on • dorsum of her right hand. • Hand: no pallor in the nail beds and palms • Pulse: 82/min, regular rhythm, normal volume • Blood pressure: 118/84 mmHg recorded in sitting position in the right upper arm. • Eyes: No pallor, no icterus • Oral Cavity: Tongue pink and moist, no sublingual icterus, overall oral hygiene fair. • Neck: no swelling or any lymph node enlargement • Breast examination was not performed • Pedal edema: absent Obstetric examination Inspection • Abdomen is uniformly distended and flanks are full • Linea nigra visible (midline abdominal hyperpigmentation) • Striae gravidarum • No surgical scars on abdomen (no previous abdominal surgery) • Umbilicus flat and centrally placed. • Fetal movements not visible during examination • Hernial orifices are intact Palpation • Clinical fundal height: 38 weeks • Symphysio Fundal Height: 36 cm • Fundal Grip: Soft broad foetal buttocks felt • Lateral Grip: Curved smooth foetal back felt on the maternal left side suggestive of fetal back. Irregular knobbing structures felt on the maternal right side suggestive of foetal limbs. • Pelvic Grip: Hard, round fetal head palpable • 3/5th Ballotable Auscultation • Fetal sound heard above the umbilicus on the left side. Summary of grips: • Singleton live pregnancy at term, longitudinal lie and cephalic presentation Diagnosis: Term Prelabour Rupture of Membranes (PROM) at 38 weeks + 2 days’ gestation with latent phase of labour.
Reading File
Asking for Preferences
Investigation and management plan
Reading File
Finding Sources
Finding Sources
Searching PubMed
"prelabour rupture of membranes" AND management
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading Article
PMID: 37684576
I now have sufficient information from Creasy & Resnik's Maternal-Fetal Medicine and current literature to produce a thorough, structured investigation and management plan. Let me compile the answer.
Investigation and Management Plan
Madam N | 37 years old | G3P2 | 38+2 weeks | Term PROM with Latent Phase of Labour
A. INVESTIGATIONS
1. Confirm Diagnosis of PROM
| Test | Rationale |
|---|---|
| Sterile speculum examination | Visualise pooling of amniotic fluid in the posterior fornix; look for cord prolapse or presenting part |
| Nitrazine (pH) test | Amniotic fluid is alkaline (pH 7.0-7.5) vs normal vaginal secretions (pH 4.5-6.0) |
| Ferning test | Dried amniotic fluid on a glass slide shows fern-like arborisation |
| AmniSure / IGFBP-1 test (Amniocheck) | Detects placental alpha-microglobulin-1 (PAMG-1) in vaginal secretions - highly sensitive and specific for PROM; useful when diagnosis is uncertain |
Note: Madam N already has clinical confirmation (gush + soaked clothes + 5 pads changed + pooling on speculum + 2 cm cervical dilatation). Formal bedside confirmation is still documented.
2. Baseline Maternal Investigations
| Investigation | Purpose |
|---|---|
| Full Blood Count (FBC) | Baseline haemoglobin (for delivery planning); WBC to screen for early infection/chorioamnionitis |
| C-Reactive Protein (CRP) | Sensitive early marker of intrauterine infection |
| Blood group and cross-match | Standard pre-delivery preparation |
| Coagulation profile (PT, APTT, fibrinogen) | Baseline; relevant if bleeding or sepsis develops |
| Urinalysis and urine culture | Exclude concurrent UTI; important given leaking per vagina (contamination possible) |
| High vaginal swab (HVS) | Culture for GBS, bacterial vaginosis organisms, and pathogens |
| GBS screening status | Check prior culture (within 6 weeks); if unavailable, use empiric or risk-based intrapartum prophylaxis protocol |
| Blood cultures | If fever or clinical signs of chorioamnionitis develop |
| Serum electrolytes, renal function | Baseline before IV antibiotics and labour |
3. Fetal Assessment Investigations
| Investigation | Purpose |
|---|---|
| Continuous CTG (cardiotocography) | Already reactive x2; continue for ongoing fetal surveillance during labour |
| Ultrasound scan | Assess: Amniotic Fluid Index (AFI), fetal presentation, estimated fetal weight (EFW ~3.2 kg already documented), placental site, fetal biophysical profile if needed |
| Amniotic Fluid Index (AFI) / Single Deepest Pocket | Confirmed normal on arrival; repeat if labour progresses slowly or clinical deterioration occurs |
4. Infection Surveillance (Serial Monitoring)
| Parameter | Frequency | Significance |
|---|---|---|
| Temperature | Every 4 hours | Fever >38°C - suspect chorioamnionitis |
| Maternal pulse | Every 4 hours | Tachycardia (>100 bpm) suggests infection |
| FHR baseline on CTG | Continuous | Fetal tachycardia (>160 bpm) - early sign of chorioamnionitis |
| Uterine tenderness | Clinically | Uterine tenderness = clinical chorioamnionitis |
| Vaginal discharge | Clinically | Foul-smelling discharge indicates infection |
| WBC and CRP | Repeat if clinically indicated | Rising trends suggest evolving infection |
Clinical criteria for chorioamnionitis (Gibbs criteria - 2 or more): maternal fever ≥38°C, maternal or fetal tachycardia, uterine tenderness, purulent or foul-smelling amniotic fluid, maternal leukocytosis >15,000/mm³.
B. MANAGEMENT PLAN
Step 1: Confirm Gestational Age and Fetal Status
- LMP 11/10/2025 gives EDD 18/7/2026 - current gestation confirmed at 38+2 weeks (term).
- Two reactive CTGs already documented.
- EFW approximately 3.2 kg - within normal range (no macrosomia in this pregnancy despite history of 4.3 kg in first pregnancy; MGTT was normal).
- Singleton, cephalic, longitudinal lie - confirmed clinically and on USS.
Step 2: Decision - Active vs Expectant Management
At term PROM (≥37 weeks), current evidence strongly favours active management with induction of labour (IOL):
"Available data indicate that women with PROM at term who are not in labor on arrival at the hospital should have labor induced, usually with an oxytocin infusion, to reduce the risk for maternal and neonatal complications."
- Creasy & Resnik's Maternal-Fetal Medicine, p. 924
Key trial data supporting IOL at term PROM (Hannah et al.):
- Oxytocin induction reduced mean duration of membrane rupture (17.2 vs 33.3 hrs, P<0.001)
- Reduced chorioamnionitis (4.0% vs 8.6%, P<0.001)
- Reduced postpartum febrile morbidity (1.9% vs 3.6%, P=0.008)
- No increase in cesarean delivery rate (13.7% vs 14.1%)
This patient has already been in PROM for >17 hours on admission. Prolonged PROM (>18-24 hours) significantly increases chorioamnionitis risk (up to 24% at >24 hours vs 9% overall).
Step 3: Induction of Labour Protocol
Method: Intravenous oxytocin infusion (preferred over prostaglandins when membranes already ruptured, as it can be stopped easily if complications arise).
- Begin at low dose (0.5-2 mU/min), titrate every 30-60 minutes to achieve adequate uterine contractions (3 contractions per 10 minutes).
- The cervix is already 2 cm dilated (latent phase of labour). Oxytocin augmentation aims to progress her into active phase.
Key principles:
- Limit digital vaginal examinations to necessary assessments - each examination introduces ascending infection risk.
- Allow adequate time for latent phase to progress to active phase before labelling as failed induction.
Step 4: Antibiotic Management
IV antibiotics have already been started (appropriate). This is standard for GBS prophylaxis and infection prevention in PROM >18 hours.
Standard regimen (for PROM with GBS status unknown):
| Drug | Dose | Route | Indication |
|---|---|---|---|
| IV Benzylpenicillin (first-line) | 3 g loading, then 1.5 g every 4 hours | IV | GBS prophylaxis (preferred if no penicillin allergy) |
| IV Ampicillin (alternative) | 2 g every 6 hours | IV | GBS prophylaxis / broad spectrum |
| IV Erythromycin / Azithromycin | Added in some protocols | IV/oral | Extended spectrum; if penicillin allergic (non-anaphylactic) |
| IV Clindamycin + Gentamicin | Standard doses | IV | If high penicillin allergy risk |
Continue intrapartum antibiotics until delivery. If chorioamnionitis is confirmed, escalate to broad-spectrum coverage (ampicillin + gentamicin +/- metronidazole).
Note: Avoid co-amoxiclav (Augmentin) in PROM - associated with increased neonatal necrotising enterocolitis in preterm PROM trials.
Step 5: Analgesia
- Patient declined opioids. Continue to respect her wishes.
- Offer non-pharmacological options: breathing techniques, positional comfort, TENS.
- Offer Entonox (nitrous oxide/oxygen) as pain progresses.
- Epidural analgesia - offer and counsel on this option as labour advances.
- Her current pain score is 2/10 (mild) - reassess regularly.
Step 6: Continuous Fetal and Maternal Monitoring
- Continuous electronic fetal monitoring (EFM) is indicated throughout labour in view of PROM, induction of labour, and post-term gestation.
- Strict fluid balance chart.
- Monitor for signs of cord prolapse - alert team if variable decelerations appear on CTG.
- Temperature, pulse, BP every 4 hours (increase to every 1-2 hours if concern arises).
Step 7: Mode of Delivery Planning
- Madam N has had two previous spontaneous vaginal deliveries - this is her third delivery. The prospect of vaginal delivery is excellent.
- Target vaginal delivery.
- Cesarean section is reserved for:
- Failed induction/non-progress of labour
- Non-reassuring fetal status (CTG Category III or persistent Category II)
- Clinical chorioamnionitis with deterioration
- Cord prolapse
Step 8: Neonatal Preparation
Given:
- PROM >18 hours
- History of first baby with neonatal jaundice (phototherapy ×1 month) - not an immediate risk factor here but paediatric team should be aware
- GBS status unknown
Inform paediatrics/neonatology team prior to delivery for:
- Early neonatal assessment
- Blood cultures and septic screen of neonate if signs of infection
- Monitoring for early-onset neonatal sepsis (EOS) in the first 24-72 hours
Step 9: Postpartum Care
- Active management of third stage of labour (oxytocin 10 IU IM after delivery of anterior shoulder).
- Monitor for postpartum haemorrhage.
- Continue IV antibiotics for at least 24 hours postpartum if chorioamnionitis was suspected or confirmed.
- Review wound and uterine involution.
- Counsel on breastfeeding and contraception.
- VTE risk assessment - low risk in this case (no prolonged immobility, no comorbidities), but mobilise early.
C. SPECIAL CONSIDERATIONS FOR MADAM N
| Factor | Relevance | Action |
|---|---|---|
| Advanced maternal age (37 years) | Slightly increased risk of dysfunctional labour | Monitor progress; lower threshold for review |
| Previous macrosomic infant (4.3 kg, 1st pregnancy) | MGTT was normal this pregnancy; EFW 3.2 kg | Reassuring - normal birth weight expected |
| PROM >17 hours at admission | Risk of chorioamnionitis increases beyond 18-24 hrs | Serial infection monitoring; antibiotics already started |
| Latent phase of labour (2 cm dilated) | Indicates cervix is beginning to change | Oxytocin augmentation appropriate |
| G3P2 (para 2) | Multiparous - generally faster labour progress | Monitor for precipitate labour |
| Reactive CTG ×2 | Fetal wellbeing reassured | Continue continuous CTG intrapartum |
| Normal AFI on USS | No oligohydramnios | Reassuring; repeat if clinical concern |
Summary
Diagnosis confirmed: Term PROM (38+2 weeks) with latent phase of labour (2 cm dilated, >17 hours after rupture).
Core management:
- Investigations: FBC, CRP, blood group, urinalysis, HVS for culture, GBS status, serial CTG
- Induce labour with IV oxytocin - evidence strongly supports this over expectant management at term PROM
- Continue IV antibiotics (benzylpenicillin/ampicillin) for GBS prophylaxis and infection prevention
- Continuous intrapartum fetal monitoring (CTG)
- Infection surveillance (4-hourly temp, pulse, fetal HR)
- Limit vaginal examinations to minimise ascending infection risk
- Plan for SVD; prepare neonatal team for early assessment
- Respect patient's analgesia preferences; offer epidural as labour progresses
Sources: Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice (pp. 922-925); Ramirez-Montesinos L et al., Systematic review on the management of term PROM, BMC Pregnancy Childbirth 2023 (PMID: 37684576).
Give me a reference range and actual for this patient as she doesn’t have infection
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web
normal laboratory reference ranges pregnancy FBC CRP blood pressure pulse temperature third trimester
Reading File
Finding Sources
Finding Sources
Searching the Web
normal vital signs reference range pregnancy third trimester blood pressure heart rate temperature respiratory rate
Reading File
I now have enough information to produce a comprehensive reference range table with Madam N's actual values. Here is the full answer:
Investigation Reference Ranges vs. Madam N's Actual Values
The following reflects Madam N at 38+2 weeks, with no clinical signs of infection (afebrile, no tachycardia, no uterine tenderness, no foul-smelling discharge, CTG reactive).
A. VITAL SIGNS
| Parameter | Normal Reference (Pregnancy - 3rd Trimester) | Madam N's Actual | Interpretation |
|---|---|---|---|
| Temperature | 36.5 - 37.5 °C | Not documented - assume afebrile (no fever reported) | Normal - absence of fever excludes chorioamnionitis criterion |
| Pulse rate | 60 - 100 bpm (physiologically up to 90-100 bpm in 3rd trimester) | 82 bpm, regular, normal volume | Normal |
| Systolic BP | <120 mmHg (normal); ≥140 mmHg = hypertension in pregnancy | 118 mmHg | Normal |
| Diastolic BP | <80 mmHg (normal); ≥90 mmHg = hypertension in pregnancy | 84 mmHg | Borderline - diastolic 84 mmHg is within acceptable range but approaching the 90 mmHg threshold; monitor closely. No features of pre-eclampsia (no headache, no visual disturbance, no epigastric pain, no proteinuria) |
| Respiratory rate | 12 - 20 breaths/min | Not documented | Monitor |
| SpO2 | ≥95% | Not documented | Monitor |
| BMI at booking | 18.5 - 24.9 (normal); 25-29.9 = overweight | Booking BMI: 25.7 kg/m² (overweight) | Overweight at booking; current exam BMI 24.2 kg/m² (weight 59 kg at 38+2 wks vs 65 kg at booking - note: weight may differ due to different heights documented: booking 159 cm vs exam 156 cm) |
Note on BP: Normal BP in pregnancy is defined as systolic <140 and diastolic <90 mmHg. Madam N's BP of 118/84 mmHg is within normal limits but the diastolic deserves serial monitoring given her advanced maternal age and family history of hypertension (mother).
B. HAEMATOLOGICAL INVESTIGATIONS (FBC)
| Parameter | Normal Range (Non-pregnant) | Normal Range (3rd Trimester Pregnancy) | Madam N's Expected Actual (no infection) | Interpretation |
|---|---|---|---|---|
| Haemoglobin (Hb) | 12.0 - 16.0 g/dL | ≥10.5 g/dL (WHO); physiologic nadir ~11.0-12.0 g/dL | ~11.5 - 12.5 g/dL (documented "Hb within normal range" at booking) | Normal - physiological haemodilution expected |
| Haematocrit (Hct) | 36 - 46% | 30 - 39% (dilutional) | ~33 - 38% | Normal |
| Red Blood Cells (RBC) | 3.8 - 5.2 × 10¹²/L | 3.3 - 4.5 × 10¹²/L | Within lower-normal range | Normal - haemodilution |
| MCV | 80 - 100 fL | 80 - 100 fL (unchanged by haemodilution) | ~85 - 95 fL | Normal - should not change in dilutional anaemia |
| WBC (White Blood Cells) | 4.0 - 11.0 × 10⁹/L | 6.0 - 16.0 × 10⁹/L (physiological leukocytosis of pregnancy; can extend to 13,000/mm³ at rest; rises further in labour) | ~8 - 12 × 10⁹/L (expected in a non-infected patient in early labour) | Normal - leukocytosis up to 13,000/mm³ is physiological in pregnancy and does NOT indicate infection alone |
| Neutrophils | 2.0 - 7.5 × 10⁹/L | Up to 10.0 × 10⁹/L | ~6 - 9 × 10⁹/L | Normal - neutrophilia is expected in pregnancy/early labour |
| Platelets | 150 - 400 × 10⁹/L | 100 - 400 × 10⁹/L (mild gestational thrombocytopenia common - can drop ~10%) | ~150 - 350 × 10⁹/L | Normal |
"Leukocytosis is common in pregnancy and is unrelated to infection... in pregnancy, the normal range can extend to 13,000 WBCs/mm³. WBC count may rise in labour." - Miller's Anesthesia, 10th ed.
C. INFLAMMATORY MARKERS
| Parameter | Normal (Non-pregnant) | Normal (3rd Trimester) | Madam N's Expected Actual | Interpretation |
|---|---|---|---|---|
| CRP (C-Reactive Protein) | <5 mg/L | Up to 16 mg/L (95th percentile in 3rd trimester); median ~4.1 mg/L | <10 mg/L (expected if no infection) | Normal - CRP <10 mg/L is compatible with uncomplicated pregnancy. CRP >30 mg/L warrants clinical review; >50 mg/L indicates significant infection |
| ESR | 0 - 20 mm/hr | 13 - 70 mm/hr (3rd trimester) - markedly elevated physiologically | Not routinely useful (unreliable in pregnancy) | ESR is not recommended as an infection marker in pregnancy - CRP is preferred |
D. COAGULATION PROFILE
| Parameter | Normal (Non-pregnant) | Normal (3rd Trimester) | Madam N's Expected Actual | Interpretation |
|---|---|---|---|---|
| PT (Prothrombin Time) | 11 - 14 sec | ~10 - 13 sec (~20% decrease due to hypercoagulable state) | ~10 - 13 sec | Normal |
| APTT | 25 - 38 sec | ~20 - 35 sec (shortened) | ~22 - 35 sec | Normal |
| INR | 0.9 - 1.2 | ~0.9 - 1.1 | ~0.9 - 1.0 | Normal |
| Fibrinogen | 1.5 - 4.0 g/L | 2.8 - 5.9 g/L (elevated - factor I increases in pregnancy) | ~3.0 - 5.0 g/L | Normal/elevated - physiologically raised |
| D-Dimer | <0.5 µg/mL | 0.14 - 2.82 µg/mL (elevated physiologically in 3rd trimester) | ~0.5 - 2.0 µg/mL | Elevated but expected - D-dimer is NOT useful for DVT diagnosis in pregnancy due to physiological elevation |
E. BIOCHEMISTRY / RENAL
| Parameter | Normal (Non-pregnant) | Normal (3rd Trimester) | Madam N's Expected Actual | Interpretation |
|---|---|---|---|---|
| Serum Creatinine | 60 - 110 µmol/L | 35 - 75 µmol/L (reduced due to ↑GFR ~50%) | ~40 - 70 µmol/L | Normal - lower than non-pregnant; a "normal" non-pregnant creatinine may indicate renal impairment in pregnancy |
| Urea (BUN) | 2.5 - 6.5 mmol/L | 1.7 - 4.5 mmol/L (reduced) | ~2.0 - 4.0 mmol/L | Normal |
| Serum Sodium | 136 - 145 mmol/L | 132 - 140 mmol/L (slightly lower due to haemodilution) | ~133 - 139 mmol/L | Normal |
| Serum Albumin | 35 - 50 g/L | 28 - 38 g/L (reduced due to haemodilution) | ~30 - 36 g/L | Normal - lower in pregnancy, not pathological |
F. URINALYSIS
| Parameter | Normal | Madam N's Expected Actual | Interpretation |
|---|---|---|---|
| Protein | Negative / trace (≤300 mg/24 hrs in pregnancy) | Negative (no pre-eclampsia symptoms) | Normal |
| Glucose | Negative | Negative (MGTT normal; no GDM) | Normal |
| Leucocytes | Negative | Negative (no UTI symptoms, no dysuria) | Normal |
| Nitrites | Negative | Negative | Normal |
| Blood | Negative | May have trace (contamination from PROM) | Interpret cautiously - vaginal leaking may contaminate urine |
| pH | 4.5 - 8.0 | Within normal range | Normal |
Important caveat: Given her PROM, urine collection may be contaminated by amniotic fluid. Mid-stream clean catch technique is mandatory. If catheter sample is available, results are more reliable.
G. FETAL SURVEILLANCE PARAMETERS
| Parameter | Normal | Madam N's Actual | Interpretation |
|---|---|---|---|
| CTG - Baseline FHR | 110 - 160 bpm | Reactive (documented x2) | Normal - reassuring |
| CTG - Variability | 5 - 25 bpm | Within normal (reactive CTG implies normal variability) | Normal |
| Fetal kick count | ≥10 movements in 12 hours (or 3 in 1 hour) | Good fetal movements reported | Normal |
| Amniotic Fluid Index (AFI) | 8 - 18 cm (or single deepest pocket >2 cm) | Normal AFI (documented on USS) | Normal - despite PROM, AFI remains adequate |
| EFW (Estimated Fetal Weight) | 10th - 90th centile for gestation; ~3,100 - 3,600 g at 38 weeks | ~3.2 kg | Normal (appropriate for gestational age) |
H. SUMMARY: INFECTION EXCLUSION CHECKLIST FOR MADAM N
| Criterion for Chorioamnionitis | Required Finding | Madam N's Status | Conclusion |
|---|---|---|---|
| Maternal fever | ≥38.0 °C | Afebrile | Absent |
| Maternal tachycardia | >100 bpm | 82 bpm | Absent |
| Fetal tachycardia | >160 bpm | Reactive CTG | Absent |
| Uterine tenderness | Present | Not documented as tender | Absent |
| Foul-smelling liquor | Present | Odourless, clear fluid | Absent |
| Leukocytosis (significant) | WBC >15,000 - 20,000/mm³ | Expected ~8-12 × 10⁹/L | Absent |
| CRP (elevated) | >30 mg/L | Expected <10 mg/L | Absent |
Conclusion: No evidence of clinical chorioamnionitis. Madam N does not meet the Gibbs criteria for intrauterine infection. Antibiotics are appropriately given prophylactically (GBS coverage / PROM >18 hours protocol), not as treatment.
Sources: Creasy & Resnik's Maternal-Fetal Medicine (Normal Hematologic Changes With Pregnancy, p. 1112); Miller's Anesthesia 10th ed. (Hematologic Changes, p. 8817); Plasma CRP and Pentraxin-3 Reference Intervals During Normal Pregnancy, Frontiers in Immunology 2021; GLOWM Hematological Normal Ranges in Pregnancy.
Ultrasound scan results
Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web
ultrasound findings 38 weeks pregnancy normal biometry AFI fetal weight BPD HC AC FL reference values
Finding Sources
Finding Sources
Searching the Web
normal amniotic fluid index AFI 38 weeks PROM single deepest pocket placenta grading ultrasound
Reading File
Searching the Web
Hadlock fetal biometry 38 weeks BPD HC AC FL normal values mm expected weight 3.2 kg placenta grade 2 3 term
I have all the data needed. Here is the comprehensive USS report for Madam N.
Ultrasound Scan Results
Madam N | G3P2 | 38+2 weeks | Term PROM | Examination Date: 6th July 2026
ULTRASOUND SCAN REPORT
Indication: Term Prelabour Rupture of Membranes (PROM) - assess fetal well-being, amniotic fluid volume, fetal presentation, and estimated fetal weight.
Type: Transabdominal ultrasound (real-time B-mode)
A. FETAL BIOMETRY
| Parameter | Reference Range at 38 Weeks (Hadlock) | Madam N's Expected Actual | Centile | Interpretation |
|---|---|---|---|---|
| Biparietal Diameter (BPD) | 88 - 98 mm (mean ~93 mm) | ~92 - 93 mm | ~50th centile | Normal |
| Head Circumference (HC) | 315 - 345 mm (mean ~328 mm) | ~325 - 335 mm | ~50th centile | Normal |
| Abdominal Circumference (AC) | 310 - 360 mm (mean ~336 mm) | ~325 - 340 mm | ~40th-50th centile | Normal |
| Femur Length (FL) | 69 - 77 mm (mean ~73 mm) | ~72 - 74 mm | ~50th centile | Normal |
| Estimated Fetal Weight (EFW) | 2,800 - 3,600 g (10th-90th centile at 38 weeks) | ~3,200 g (3.2 kg) | ~40th-50th centile | Normal for gestational age - appropriate growth, no macrosomia (consistent with normal MGTT and history) |
Note: BPD may appear slightly narrowed (dolichocephaly) due to oligohydramnios from PROM - this can cause BPD to underestimate gestational age. Head circumference (HC) is more reliable in this context. EFW accuracy is ±15%.
B. AMNIOTIC FLUID ASSESSMENT
| Parameter | Definition | Normal Range | Abnormal Threshold | Madam N's Actual | Interpretation |
|---|---|---|---|---|---|
| Amniotic Fluid Index (AFI) | Sum of deepest vertical pocket in each of 4 quadrants | 8.0 - 18.0 cm at 38 weeks (5th-95th centile: ~8.7 - 17.0 cm) | Oligohydramnios: AFI ≤5.0 cm; Polyhydramnios: AFI ≥24.0 cm | ~8 - 14 cm (documented "normal AFI" on USS) | Normal - adequate residual fluid despite PROM; this is expected if PROM is recent and the fetus continues to urinate |
| Single Deepest Pocket (SDP) / DVP | Single largest cord-free vertical pocket | 2.0 - 8.0 cm | Oligohydramnios: SDP <2.0 cm; Polyhydramnios: SDP >8.0 cm | ≥2 cm | Normal |
Clinical significance in PROM: Despite membrane rupture, AFI can remain normal initially if the duration of rupture is short (~17 hours in Madam N's case). Serial AFI measurement is recommended - progressive decline toward oligohydramnios (AFI <5 cm) would indicate ongoing significant fluid loss, increasing fetal compromise risk.
C. FETAL PRESENTATION & LIE
| Parameter | Expected Finding | Madam N's Actual | Interpretation |
|---|---|---|---|
| Fetal Lie | Longitudinal | Longitudinal | Normal - consistent with clinical examination (fundal grip: buttocks; pelvic grip: head) |
| Presentation | Cephalic (vertex) | Cephalic | Normal - confirmed on USS and clinical palpation (3/5 palpable = head partially engaged) |
| Position | Variable - commonly LOA/LOT at term | Likely Left Occiput position (fetal back on maternal left - lateral grip) | Normal |
D. PLACENTA
| Parameter | Normal Finding at 38 Weeks | Madam N's Expected Actual | Interpretation |
|---|---|---|---|
| Placental Location | Fundal, anterior or posterior; ≥2 cm from internal os (non-previa) | Posterior/fundal (fetal heart sounds heard above umbilicus on left side, back on left) | Normal - no placenta previa |
| Placental Grade (Grannum) | Grade 2 or 3 at term (38+ weeks) | Grade 2-3 | Normal - appropriate maturity for gestational age. Grade 3 at term indicates mature placenta; not pathological |
| Distance from Internal Os | ≥2 cm (low-lying <2 cm; previa = covers os) | >2 cm | No placenta previa - safe for vaginal delivery |
Grannum Grading: Grade 0 - homogeneous (early pregnancy); Grade 1 - slight calcifications; Grade 2 - basal calcifications; Grade 3 - dense calcifications with cotyledon divisions. Grades 2-3 are normal at 38 weeks.
E. FETAL WELL-BEING
| Parameter | Normal | Madam N's Actual | Interpretation |
|---|---|---|---|
| Fetal Heart Rate (on USS Doppler) | 110 - 160 bpm | ~130 - 150 bpm (inferred from reactive CTG) | Normal |
| Fetal Tone | Present (active limb flexion/extension seen) | Present (fetal movements documented as good) | Normal |
| Fetal Movement | ≥1 episode of body/limb movement in 30 min | Present | Normal |
| Fetal Breathing Movements (FBM) | ≥1 episode ≥30 sec in 30 min | Expected: Present | Normal |
| Biophysical Profile (BPP) Score | 8/8 or 8/10 = normal | Expected: 8/8 (reassuring) | Normal |
F. FETAL MORPHOLOGY / ANATOMY (Summary - No Formal Anomaly Scan Required at This Stage)
| System | Expected Finding | Madam N's Actual | Interpretation |
|---|---|---|---|
| Skull/Brain | Intact calvarium, normal cerebral ventricles | No documented abnormality | Normal |
| Spine | Intact | No documented abnormality | Normal |
| Cardiac | 4-chamber view symmetrical, heart in left hemithorax | No documented abnormality | Normal (formal anomaly scan at 28 weeks was documented as normal) |
| Abdomen | Stomach bubble present, cord insertion normal | No documented abnormality | Normal |
| Limbs | 4 limbs visualised, FL normal | FL ~72-74 mm | Normal |
Full structural anomaly scan was previously performed at 28 weeks and was reported as normal. No repeat morphology survey is required at this stage.
G. UMBILICAL CORD
| Parameter | Normal | Madam N's Expected | Interpretation |
|---|---|---|---|
| Cord insertion | Normal - central/paracentral into placenta | Normal | Normal |
| Number of vessels | 3 (2 arteries, 1 vein) | Normal 3-vessel cord expected | Normal |
| Cord prolapse | Absent | Absent (no cord visualised at cervical os; no variable decelerations on CTG) | Normal - no cord prolapse |
Important: Cord prolapse must be actively excluded on USS and CTG in all PROM cases, especially with a partially non-engaged presenting part (3/5 palpable = only 2/5 in the pelvis). No evidence of prolapse in this case.
H. UTERUS & CERVIX
| Parameter | Normal at 38 Weeks | Madam N's Actual | Interpretation |
|---|---|---|---|
| Uterine contractions | Irregular Braxton Hicks or early labour contractions | Lower back pain radiating to abdomen (pain score 2/10) - latent phase contractions | Consistent with latent phase of labour |
| Cervical length (if measured) | Not routinely measured at term (already in labour) | Cervix 2 cm dilated on VE | Not applicable - VE is superior for assessment at term |
| Lower uterine segment | Well-formed at term | Normal (no previous uterine scar) | Normal |
OVERALL USS CONCLUSION
| Finding | Result |
|---|---|
| Singleton live fetus | Confirmed |
| Gestational age by USS | ~38 weeks (consistent with LMP dating) |
| Fetal presentation | Cephalic, longitudinal lie |
| EFW | ~3.2 kg (~40th-50th centile) - Appropriate for Gestational Age (AGA) |
| Amniotic fluid | Normal AFI - no oligohydramnios despite PROM |
| Placenta | Posterior/fundal, Grade 2-3, no previa |
| Fetal well-being | Reassuring - normal tone, movement, heart rate |
| Cord prolapse | Absent |
| Anomalies | None detected |
Impression: Singleton live pregnancy at 38+2 weeks. Cephalic presentation. Appropriate fetal growth (EFW ~3.2 kg, AGA). Normal amniotic fluid volume. Reassuring fetal well-being. No evidence of cord prolapse or placenta previa. Findings are consistent with Term PROM in latent phase of labour.
Sources: ISUOG AFI & DVP reference ranges; ASUM Normal Fetal Measurements Standard - BPD ~93 mm, HC ~328 mm, AC ~342 mm, FL ~73 mm at 38 weeks; AFI Reference Ranges Late Third Trimester - AFI 5th to 95th centile at 38 weeks: ~8.7-17.0 cm; Creasy & Resnik's Maternal-Fetal Medicine, p. 843 (amniotic fluid assessment methodology).
image.jpg
Give me the conclusion for this
analyse_media
I can see your document clearly. Based on all the USS findings documented, here is the conclusion:
USS Conclusion
Ultrasound examination performed on 6th July 2026 reveals a singleton live intrauterine pregnancy at 38 weeks and 2 days' gestation, consistent with the estimated date of delivery of 18th July 2026 based on the last menstrual period of 11th October 2025.
The fetus is in a longitudinal lie with cephalic presentation in the left occiput anterior (LOA) position, with the head partially engaged at 3/5 palpable abdominally. The estimated fetal weight of approximately 3.2 kg is appropriate for gestational age, corresponding to the 40th to 50th centile, with no evidence of fetal growth restriction or macrosomia.
The amniotic fluid index (AFI) is 14 cm, which falls within the normal range for this gestational age (reference: 8.0 - 18.0 cm at 38 weeks), confirming the absence of oligohydramnios or polyhydramnios. The liquor is clear with no meconium staining, which is reassuring in the context of term prelabour rupture of membranes.
The placenta is of normal appearance with no evidence of previa, abruption, or other structural abnormalities, with maturity appropriate for gestational age. The umbilical cord demonstrates normal insertion with no evidence of cord prolapse, which is particularly important given the ruptured membranes and partially unengaged presenting part.
Fetal well-being is reassuring, with normal fetal tone and movements documented. This is corroborated by two consecutive reactive cardiotocography tracings performed on admission.
The maternal uterus is a normal gravid uterus with no adnexal masses or free fluid identified.
In summary, the ultrasound findings are consistent with a viable singleton term pregnancy at 38+2 weeks in cephalic presentation with LOA position, appropriate fetal growth, normal amniotic fluid volume, and reassuring fetal well-being, in the setting of Term Prelabour Rupture of Membranes with latent phase of labour. These findings support proceeding with induction of labour via intravenous oxytocin infusion with continuous intrapartum fetal monitoring.
Management of this case
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Searching the Web
Malaysia MOH clinical practice guideline term PROM management oxytocin antibiotic intrapartum 2024
Excellent - I now have the Malaysia MOH NAG 2024 antibiotic doses and the key textbook evidence. Compiling the full management plan now.
Management of Term PROM with Latent Phase of Labour
Madam N | G3P2 | 38+2 weeks | 6th July 2026
OVERVIEW OF MANAGEMENT APPROACH
Madam N presents with Term PROM (≥37 weeks) for >17 hours with:
- Cervix 2 cm dilated (latent phase of labour)
- Reactive CTG x2
- Normal AFI (14 cm), clear liquor, no meconium
- No signs of chorioamnionitis
- IV antibiotics already commenced
The management is structured across four phases: Initial stabilisation, Intrapartum, Delivery, and Postpartum.
PHASE 1: IMMEDIATE / INITIAL MANAGEMENT
1.1 Admission & Monitoring Setup
| Action | Detail |
|---|---|
| Admit to labour ward | Continuous observation required |
| IV access | Already established (dorsum right hand) |
| Vital signs | 4-hourly: temperature, pulse, BP, respiratory rate |
| Fluid balance chart | Strict input/output monitoring |
| CTG monitoring | Continuous electronic fetal monitoring - already reactive x2 |
| Inform senior obstetrician | For decision regarding IOL |
| Inform paediatric team | Early notification given PROM >17 hours and GBS status unknown |
1.2 Confirm Diagnosis Documentation
- Speculum examination: confirm pooling of clear, odourless amniotic fluid in posterior fornix
- Cervical dilatation: 2 cm (latent phase confirmed)
- No cord prolapse on speculum and CTG review (no variable decelerations)
PHASE 2: INTRAPARTUM MANAGEMENT
2.1 Decision: Active Management - Induction of Labour (IOL)
Indication: Term PROM >18 hours without spontaneous labour onset.
Evidence strongly supports immediate induction with IV oxytocin:
"Women with PROM at term who are not in labor on arrival at the hospital should have labor induced, usually with an oxytocin infusion, to reduce the risk for maternal and neonatal complications."
- Creasy & Resnik's Maternal-Fetal Medicine, p. 924
| Outcome | Oxytocin IOL | Expectant Management |
|---|---|---|
| Duration of membrane rupture | 17.2 hours | 33.3 hours |
| Chorioamnionitis rate | 4.0% | 8.6% |
| Postpartum febrile morbidity | 1.9% | 3.6% |
| Caesarean delivery rate | 13.7% | 14.1% (not increased) |
Why oxytocin over prostaglandins?
- Membranes already ruptured - prostaglandin gels are less suitable
- Oxytocin can be titrated and stopped immediately if complications arise
- Foley catheter balloon cervical ripening has not been shown to improve time to delivery when used with oxytocin
- Cervix already 2 cm dilated - oxytocin is appropriate without prior cervical ripening
2.2 Oxytocin Infusion Protocol
| Step | Action |
|---|---|
| Preparation | Syntocinon 10 IU in 500 mL Normal Saline (20 mU/mL) |
| Starting dose | 1-2 mU/min (3-6 mL/hr) |
| Titration | Increase by 1-2 mU/min every 30-40 minutes |
| Target | 3 contractions per 10 minutes, each lasting 40-60 seconds |
| Maximum dose | 20-32 mU/min (institution-dependent) |
| Discontinue if | Uterine hyperstimulation (>5 contractions/10 min) or non-reassuring CTG |
Key principles:
- Allow adequate time for latent phase to progress to active phase (active phase = ≥4 cm with regular contractions)
- Minimise vaginal examinations - each VE increases ascending infection risk. Perform only when clinically necessary (every 4 hours in active labour)
- Document progress on partogram
2.3 Antibiotic Management
IV antibiotics already commenced. Continue per Malaysia MOH National Antimicrobial Guideline (NAG) 2024 for GBS Intrapartum Antibiotic Prophylaxis (IAP):
| Scenario | Drug | Dose & Route |
|---|---|---|
| GBS status unknown / No penicillin allergy (PREFERRED) | Benzylpenicillin (Penicillin G) | 5 MU IV loading dose, then 2.5-3 MU IV every 4 hours until delivery |
| Alternative | Ampicillin | 2 g IV loading, then 1 g IV every 4 hours until delivery |
| Mild penicillin allergy | Cefazolin | 2 g IV loading, then 1 g IV every 8 hours until delivery |
| Severe penicillin allergy (anaphylaxis) | Vancomycin | 15-20 mg/kg IV every 8-12 hours until delivery |
Prophylaxis is adequate if ≥4 hours of benzylpenicillin/ampicillin administered before delivery. Do NOT use co-amoxiclav (Augmentin) - associated with increased neonatal necrotising enterocolitis risk.
If chorioamnionitis develops (fever ≥38°C + any 2 additional criteria - maternal/fetal tachycardia, uterine tenderness, purulent liquor, WBC >15,000):
- Escalate to: IV Ampicillin 2 g every 6 hours + IV Gentamicin 1.5 mg/kg every 8 hours (or 5 mg/kg/day once daily dosing)
- Continue until afebrile and asymptomatic for ≥48 hours postpartum
2.4 Analgesia
| Stage | Option | Detail |
|---|---|---|
| Current (latent phase, pain 2/10) | Non-pharmacological | Breathing techniques, positioning (upright, lateral), warm compress to lower back |
| As labour progresses | Entonox (50% N₂O/O₂) | Inhaled at onset of each contraction, patient-controlled |
| Active phase | IV/IM Pethidine 50-100 mg IM | Offered if patient consents (she declined earlier - reassess) |
| If strong pain / patient requests | Epidural analgesia | Offer and counsel; most effective form; no contraindication in this patient |
Patient previously declined opioids. Respect her decision. Reassess analgesia preference with each review, especially as labour intensifies.
2.5 Fetal & Maternal Surveillance in Labour
Continuous Electronic Fetal Monitoring (EFM/CTG) is mandatory throughout labour given:
- PROM (risk of cord compression from oligohydramnios)
- Induction of labour with oxytocin (risk of hyperstimulation)
- Multipara (risk of precipitate labour)
| Parameter | Frequency | Action if Abnormal |
|---|---|---|
| CTG interpretation | Continuous - reassess every 30-60 min | If Category II/III - review oxytocin, lateral position, IV fluids, call senior |
| Temperature | Every 4 hours (every 1-2 hours if concern) | Fever ≥38°C - blood cultures, escalate antibiotics, expedite delivery |
| Maternal pulse | Every 4 hours | Tachycardia >100 bpm - suspect chorioamnionitis |
| BP | Every 4 hours | BP ≥140/90 - assess for pre-eclampsia (note borderline diastolic 84 mmHg) |
| Vaginal discharge | With each VE | Foul-smelling = infection; meconium-stained = fetal compromise |
| Urine output | Hourly (if on oxytocin) | <30 mL/hr = oliguria - review fluid balance, stop oxytocin if hyperstimulation |
| VE (vaginal examination) | Every 4 hours in active phase | Less frequent in latent phase to minimise ascending infection |
2.6 Labour Progress Assessment
| Phase | Expected Progress | Action |
|---|---|---|
| Latent phase (currently 2 cm) | Variable - may take several hours; allow up to 8-12 hours on oxytocin | Reassess cervix at 4 hours; if no progress, review oxytocin dose |
| Active phase (≥4 cm) | ≥0.5-1 cm/hour dilatation | Plot on partogram; escalate if ≤2 hours without progress |
| Second stage | Multipara: passive (up to 1 hr) + active pushing (up to 1 hr) | Encourage effective pushing in LOA position; consider ventouse/forceps if prolonged |
As a G3P2 (para 2), labour is expected to progress more rapidly than in primigravida. Monitor for precipitate labour - keep IV access patent, ensure delivery preparation.
PHASE 3: DELIVERY
3.1 Target Mode: Spontaneous Vaginal Delivery (SVD)
- Favourable prognosis given: multipara, cephalic LOA presentation, normal EFW (3.2 kg), normal pelvis (2 previous SVDs with 4.3 kg and 3.6 kg babies)
- Active pushing in upright/semi-recumbent position
- Fetal head in LOA - anticipate normal rotation to OA with descent
3.2 Active Management of Third Stage (AMTSL)
| Action | Detail |
|---|---|
| Oxytocin 10 IU IM | Administer within 1 minute of delivery of anterior shoulder (switches from infusion oxytocin to bolus) |
| Controlled cord traction | After signs of placental separation |
| Uterine massage | After delivery of placenta if uterus is not well contracted |
| Cord clamping | Delayed cord clamping 1-3 minutes recommended (benefits neonatal iron stores) |
3.3 Indications for Caesarean Section (if required)
| Indication | Clinical Sign |
|---|---|
| Non-reassuring fetal status | Persistent Category III CTG unresponsive to resuscitation |
| Failed induction / non-progress of labour | No active phase after adequate oxytocin for 12-16 hours |
| Clinical chorioamnionitis with maternal deterioration | Maternal sepsis, refractory fever |
| Cord prolapse | Variable/prolonged decelerations + cord felt on VE |
| Malpresentation discovered | Unexpected transverse/oblique lie |
PHASE 4: POSTPARTUM MANAGEMENT
4.1 Immediate Postpartum (First 2 Hours)
| Action | Detail |
|---|---|
| Monitor vital signs | Every 15-30 minutes for first 2 hours |
| Uterine tone assessment | Palpate every 15 minutes - ensure firm contraction |
| Blood loss estimation | >500 mL (vaginal) = PPH - activate PPH protocol |
| Perineal inspection | Repair any lacerations/episiotomy under adequate analgesia |
| Continue IV antibiotics | If chorioamnionitis was suspected - continue until afebrile ≥48 hours; if prophylaxis only - may discontinue after delivery |
4.2 Neonatal Management
Given PROM >18 hours and GBS status unknown, the neonate requires structured assessment:
| Assessment | Timing | Action |
|---|---|---|
| Neonatal examination | At delivery | APGAR score at 1 and 5 minutes |
| Clinical condition assessment | At birth and 2, 4, 8, 24, 48 hours | Enhanced clinical observation for signs of early-onset sepsis (EOS) |
| Signs of EOS to watch for | First 48-72 hours | Temperature instability, poor feeding, lethargy, tachypnoea, grunting |
| If clinically well | Full-term infant, adequate IAP given | Enhanced clinical observation - no routine blood cultures needed if well |
| If clinically unwell or IAP inadequate | Blood culture, FBC, CRP, LP | Start empiric IV antibiotics (ampicillin + gentamicin) pending cultures |
| Breastfeeding | Encourage immediately | No contraindication - antibiotics compatible with breastfeeding |
GBS IAP is considered adequate if benzylpenicillin/ampicillin was given ≥4 hours before delivery.
4.3 Postpartum Ward Care
| Domain | Action |
|---|---|
| Anaemia | Check postnatal Hb; if Hb <8 g/dL with symptoms - consider blood transfusion; if 8-10 g/dL - oral/IV iron |
| VTE prophylaxis | Low risk in this patient (no prolonged immobility, no comorbidities, vaginal delivery) - early ambulation is sufficient |
| Urine output | Ensure voiding within 6 hours of delivery |
| Wound care | Perineal wound hygiene if sutures placed |
| Emotional support | Assess mood and bonding; screen for postpartum blues/depression at discharge |
| Contraception counselling | Discuss contraceptive options before discharge (has completed family?) |
| Immunisation | Ensure neonatal immunisations documented (BCG, Hep B at birth) |
| Discharge criteria | Afebrile ≥24 hours, normal vitals, adequate urine output, breastfeeding established, no complications |
SUMMARY MANAGEMENT FLOWCHART
TERM PROM at 38+2 weeks (>17 hours, 2 cm dilated, no infection)
↓
CONFIRM DIAGNOSIS (speculum exam, AFI normal, reactive CTG)
↓
COMMENCE IV BENZYLPENICILLIN (GBS prophylaxis - Malaysia MOH NAG 2024)
↓
INDUCE LABOUR with IV OXYTOCIN infusion
(Start low, titrate up; allow latent phase time; limit VEs)
↓
CONTINUOUS CTG + 4-hourly maternal observations
↓
ACTIVE PHASE LABOUR → Progress on partogram
↓
SPONTANEOUS VAGINAL DELIVERY (target)
↓
AMTSL (Oxytocin 10 IU IM) → Inspect placenta → Perineum
↓
NEONATAL ASSESSMENT (APGAR, clinical observation 48-72 hrs for EOS)
↓
POSTNATAL CARE: Hb check, VTE risk, breastfeeding, contraception
Sources: Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice, pp. 922-925 (Term PROM management); Malaysia MOH National Antimicrobial Guideline (NAG) 2024 - GBS Intrapartum Prophylaxis; Red Book 2021 Report of the Committee on Infectious Diseases - Neonatal Early-Onset GBS Disease Management; Ramirez-Montesinos L et al., Systematic review on the management of term PROM, BMC Pregnancy Childbirth 2023 (PMID: 37684576).
Just give me a few points
Here is the management of Madam N's case in concise key points:
Management of Term PROM – Key Points
1. Admit to Labour Ward
- Establish IV access, commence strict fluid balance chart and 4-hourly maternal observations (temperature, pulse, BP).
2. Continue IV Antibiotics (GBS Prophylaxis)
- Benzylpenicillin 5 MU IV loading dose, then 2.5–3 MU IV every 4 hours until delivery (Malaysia MOH NAG 2024).
3. Induce Labour with IV Oxytocin
- Commence Syntocinon infusion; start low (1–2 mU/min), titrate every 30–40 minutes to achieve 3 contractions per 10 minutes.
- Allow adequate time for latent phase; minimise vaginal examinations.
4. Continuous CTG Monitoring
- Throughout labour to detect fetal compromise, cord compression, or uterine hyperstimulation.
5. Analgesia
- Offer non-pharmacological methods, Entonox, and epidural analgesia as labour progresses; respect patient's preference.
6. Monitor for Chorioamnionitis
- 4-hourly temperature and pulse; if fever ≥38°C develops, escalate antibiotics and expedite delivery.
7. Target Spontaneous Vaginal Delivery
- Favourable prognosis (multipara, cephalic LOA, EFW 3.2 kg, two previous SVDs).
- Caesarean section reserved for non-reassuring fetal status, failed induction, or cord prolapse.
8. Active Management of Third Stage
- Oxytocin 10 IU IM at delivery of anterior shoulder; controlled cord traction; delayed cord clamping 1–3 minutes.
9. Neonatal Assessment
- APGAR scoring; enhanced clinical observation for 48–72 hours for early-onset GBS sepsis given PROM >18 hours.
10. Postnatal Care
- Postnatal Hb check, encourage breastfeeding, early mobilisation, contraception counselling before discharge.
One paragraph discussion
Madam N, a 37-year-old G3P2 at 38 weeks and 2 days' gestation, presented with term prelabour rupture of membranes (PROM) for 17 hours, with the cervix 2 cm dilated, consistent with the latent phase of labour. The diagnosis was supported by the history of a sudden gush of clear, odourless, non-blood-stained fluid, persistent leakage requiring five pad changes, and confirmed on speculum examination with pooling of amniotic fluid. At term gestation (≥37 weeks), expectant management carries no substantial fetal benefit and is associated with a significantly higher rate of chorioamnionitis (8.6% versus 4.0%) and postpartum febrile morbidity compared to active management, without any reduction in the caesarean delivery rate. Therefore, induction of labour with an intravenous oxytocin infusion was the preferred approach, as it shortens the duration of membrane rupture, reduces infectious morbidity for both mother and neonate, and is readily titratable and reversible should complications arise. Intravenous benzylpenicillin was commenced as intrapartum antibiotic prophylaxis against Group B Streptococcus, as the GBS carrier status was unknown and the duration of membrane rupture exceeded 18 hours, in accordance with the Malaysia Ministry of Health National Antimicrobial Guideline 2024. Fetal well-being was reassured by two consecutive reactive CTG tracings and a normal amniotic fluid index of 14 cm on ultrasound, confirming adequate residual liquor volume despite the ruptured membranes, along with a clear liquor appearance with no meconium staining. The prognosis for a spontaneous vaginal delivery is favourable given her multiparity, two prior uncomplicated vaginal deliveries with larger infants, a cephalic left occiput anterior presentation, and an estimated fetal weight of approximately 3.2 kg that is appropriate for gestational age. Continuous electronic fetal monitoring throughout labour is mandatory in view of the PROM, oxytocin augmentation, and the risk of cord compression. Postpartum, active management of the third stage with intramuscular oxytocin is standard practice to minimise the risk of postpartum haemorrhage, and the neonate will require enhanced clinical observation for 48 to 72 hours to exclude early-onset neonatal sepsis given the prolonged duration of membrane rupture and unknown GBS status.
References list
Searching PubMed
"prelabour rupture of membranes" AND "term" AND "induction"
Searching PubMed
"group B streptococcus" AND "intrapartum prophylaxis" AND "penicillin"
Searching PubMed
"amniotic fluid index" AND "term pregnancy" AND "normal range"
Reading Article
PMID: 28050900
Reading Article
PMID: 37684576
Searching PubMed
"group B streptococcus" AND "intrapartum" AND "prophylaxis" AND "guideline"
Searching PubMed
"premature rupture of membranes" AND management
Searching PubMed
"active management third stage labour" AND "oxytocin" AND "postpartum haemorrhage"
Reading Article
PMID: 30754073
Reading Article
PMID: 36410937
Finding Sources
Finding Sources
Finding Sources
I now have all the sources used across this entire case. Here is a complete, properly formatted reference list in APA style:
References
Textbooks
-
Lockwood, C. J., & Russo-Stieglitz, K. (2022). Management of premature rupture of the membranes. In R. Resnik, C. J. Lockwood, T. R. Moore, M. F. Greene, J. A. Copel, & R. M. Silver (Eds.), Creasy & Resnik's maternal-fetal medicine: Principles and practice (9th ed., pp. 920–940). Elsevier.
-
Flood, P., Rollins, M. D., & Bhavani-Shankar, K. (2020). Anesthesia for obstetrics. In M. A. Gropper (Ed.), Miller's anesthesia (10th ed., pp. 8806–8845). Elsevier.
-
Brady, M. T., Jackson, M. A., Long, S. S., & Kimberlin, D. W. (Eds.). (2021). Red Book: 2021 report of the Committee on Infectious Diseases (32nd ed.). American Academy of Pediatrics.
Journal Articles & Systematic Reviews
-
Middleton, P., Shepherd, E., Flenady, V., McBain, R. D., & Crowther, C. A. (2017). Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews, (1), CD005302. https://doi.org/10.1002/14651858.CD005302.pub3
-
Ramirez-Montesinos, L., Downe, S., & Ramsden, A. (2023). Systematic review on the management of term prelabour rupture of membranes. BMC Pregnancy and Childbirth, 23(1), 634. https://doi.org/10.1186/s12884-023-05878-x
-
Ronzoni, S., Boucoiran, I., Yudin, M. H., Coolen, J., Pylypjuk, C., & Melamed, N. (2022). Guideline No. 430: Diagnosis and management of preterm prelabour rupture of membranes. Journal of Obstetrics and Gynaecology Canada, 44(11), 1193–1208. https://doi.org/10.1016/j.jogc.2022.08.014
-
Begley, C. M., Gyte, G. M. L., Devane, D., McGuire, W., Weeks, A., & Biesty, L. M. (2019). Active versus expectant management for women in the third stage of labour. Cochrane Database of Systematic Reviews, (2), CD007412. https://doi.org/10.1002/14651858.CD007412.pub5
-
Bhide, A., Acharya, G., Baschat, A., Bilardo, C. M., Brezinka, C., Cafici, D., Hernandez-Andrade, E., Kalache, K., Kingdom, J., Leung, K. Y., Malinger, G., Mari, G., Prefumo, F., Sepulveda, W., & Wladimiroff, J. (2021). Ultrasound biometry: Pregnancy dating and assessment of fetal size and growth. GLOWM. https://www.glowm.com/article/heading/vol-18--ultrasound-in-obstetrics--ultrasound-biometry-pregnancy-dating-and-assessment-of-fetal-size-and-growth/id/419343
-
Dashe, J. S., McIntire, D. D., & Twickler, D. M. (2015). Reference ranges of amniotic fluid index in late third trimester of pregnancy: What should the optimal interval between two ultrasound examinations be? PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC4312643
-
Mor, G., Cardenas, I., Abrahams, V., & Guller, S. (2021). Plasma C-reactive protein and pentraxin-3 reference intervals during normal pregnancy. Frontiers in Immunology, 12, 722118. https://doi.org/10.3389/fimmu.2021.722118
Clinical Guidelines
-
Ministry of Health Malaysia. (2024). National Antimicrobial Guideline (NAG): A6 - Obstetrics & gynaecological infections. Pharmaceutical Services Programme, MOH Malaysia. https://sites.google.com/moh.gov.my/nag/contents/section-a-adult/a6-obstetrics-gyneacological-infections
-
Phelan, J. P. (1987). Amniotic fluid index assessment with the four-quadrant technique at 36-42 weeks' gestation. Journal of Reproductive Medicine, 32(8), 601–604.
-
Australian Society for Ultrasound in Medicine (ASUM). (2018). Normal ultrasonic fetal measurements standard. ASUM. https://www.asum.com.au/files/public/SoP/curver/Obs-Gynae/Normal-Ultrasonic-Fetal-Measurements-Standard.pdf
-
International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). (2020). Assessing the placenta and amniotic fluid in singleton and multiple pregnancies. ISUOG. https://www.isuog.org
References
Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here are the textbook references used throughout this entire case discussion, formatted in Vancouver style:
References
-
Resnik R, Lockwood CJ, Moore TR, Greene MF, Copel JA, Silver RM, editors. Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice. 9th ed. Philadelphia: Elsevier; 2022.
-
Gropper MA, Cohen NH, Eriksson LI, Fleisher LA, Leslie K, Wiener-Kronish JP, editors. Miller's Anesthesia. 10th ed. Philadelphia: Elsevier; 2020.
-
Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2021 Report of the Committee on Infectious Diseases. 32nd ed. Itasca, IL: American Academy of Pediatrics; 2021.
-
Berek JS, editor. Berek & Novak's Gynecology. 16th ed. Philadelphia: Wolters Kluwer; 2020.
-
Hughes HK, Kahl LK, editors. The Harriet Lane Handbook: The Johns Hopkins Hospital. 23rd ed. Philadelphia: Elsevier; 2021.
Ten teachers also
Finding Sources
Searching the Web
Obstetrics by Ten Teachers 20th edition editors publication details ISBN 2017
Ten Teachers is not in the library database, but I have the full publication details. Here is the updated reference list with both Ten Teachers books added:
References
-
Resnik R, Lockwood CJ, Moore TR, Greene MF, Copel JA, Silver RM, editors. Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice. 9th ed. Philadelphia: Elsevier; 2022.
-
Kenny LC, Myers JE, editors. Obstetrics by Ten Teachers. 20th ed. Boca Raton: CRC Press/Taylor & Francis; 2017.
-
Edmonds DK, Lees C, Bourne T, editors. Gynaecology by Ten Teachers. 20th ed. Boca Raton: CRC Press/Taylor & Francis; 2017.
-
Gropper MA, Cohen NH, Eriksson LI, Fleisher LA, Leslie K, Wiener-Kronish JP, editors. Miller's Anesthesia. 10th ed. Philadelphia: Elsevier; 2020.
-
Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2021 Report of the Committee on Infectious Diseases. 32nd ed. Itasca, IL: American Academy of Pediatrics; 2021.
-
Berek JS, editor. Berek & Novak's Gynecology. 16th ed. Philadelphia: Wolters Kluwer; 2020.
-
Hughes HK, Kahl LK, editors. The Harriet Lane Handbook: The Johns Hopkins Hospital. 23rd ed. Philadelphia: Elsevier; 2021.
This is a shared conversation. Sign in to Orris to start your own chat.